PAFAH1B1
PAFAH1B1 (platelet activating factor acetylhydrolase 1b regulatory subunit 1, also known as LIS1, PAFAH, NudF, MDCR and MDS) is the regulatory subunit of cytosolic type I PAF acetylhydrolase. It also positively regulates the microtubule motor dynein, and is required for brain development. Browse Assay Genie's current range of PAFAH1B1 research reagents below, or read on for the biology behind the target.
PAFAH1B1 is the regulatory subunit (beta subunit in UniProt; described as the non-catalytic alpha subunit in the NCBI Gene summary) of the cytosolic type I platelet-activating factor (PAF) acetylhydrolase, PAF-AH (I). This enzyme catalyses hydrolysis of the acetyl group at the sn-2 position of PAF and its analogues, and so takes part in PAF inactivation. PAFAH1B1 regulates PAF-AH (I) activity in a manner that depends on the composition of the catalytic dimer. Two other intracellular PAF acetylhydrolase isoforms exist, one multi-subunit and one single-subunit, along with a single-subunit serum form.
Beyond PAF metabolism, the protein is a positive regulator of dynein, the minus-end directed microtubule motor. It may enhance dynein-mediated microtubule sliding by targeting dynein to the microtubule plus end, and is required for dynein recruitment to plus ends and BICD2-bound cargos. Dynein- and microtubule-dependent processes that need it include maintenance of Golgi integrity, peripheral transport of microtubule fragments and coupling of the nucleus to the centrosome. UniProt places it in the cytoskeleton, centrosome and spindle, and at the nuclear membrane. It belongs to the WD repeat LIS1/nudF family.
During brain development PAFAH1B1 is required for proliferation of neuronal precursors and for migration of new neurons from the ventricular/subventricular zone towards the cortical plate, a process involving nucleokinesis. It is also needed for Rho GTPase activation and actin polymerisation at the leading edge of locomoting cerebellar and postmigratory hippocampal neurons after NMDA receptor-triggered calcium influx. It may modulate the Reelin pathway through interaction of the PAF-AH (I) catalytic dimer with VLDLR, and may contribute to fibroblast migration during wound healing. The gene was identified because its mutation or loss causes the lissencephaly of Miller-Dieker lissencephaly syndrome, which explains the alias MDCR and the previous name Miller-Dieker syndrome chromosome region. Mouse and rat orthologues are both named Pafah1b1.
PAFAH1B1 is required for proliferation of neuronal precursors and migration of new neurons towards the cortical plate during brain development.
It positively regulates dynein and is needed for dynein recruitment to microtubule plus ends and BICD2-bound cargos.
Mutation or loss of the PAFAH1B1 gene causes the lissencephaly associated with Miller-Dieker lissencephaly syndrome.
As regulatory subunit of PAF-AH (I), it controls an enzyme that hydrolyses the sn-2 acetyl group of PAF and participates in PAF inactivation.
PAFAH1B1 regulates the cytosolic type I PAF acetylhydrolase, which inactivates platelet-activating factor, and positively regulates dynein. Through dynein it supports Golgi integrity, nucleus–centrosome coupling, and neuronal precursor proliferation and migration during brain development.
The gene is known as LIS1, PAFAH, NudF, MDCR and MDS. LIS1 reflects lissencephaly, NudF reflects the fungal homologue family, and MDCR refers to the Miller-Dieker syndrome chromosome region. Earlier names described it as the 45 kDa alpha subunit of PAF acetylhydrolase isoform Ib.
Mouse and rat both have an orthologue named Pafah1b1. In humans, mutation or loss of the gene causes the lissencephaly of Miller-Dieker lissencephaly syndrome. Check the datasheet of any product for its validated reactivity.
Other platelet-activating factor acetylhydrolase family members that act alongside PAFAH1B1.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P43034; product specifications from Assay Genie datasheets.